Clinical Trials

NCT05372614 | RECRUITING | PHASE1
58 participants

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2022-10-05
Completion:
2028-07-17
Conditions
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Pancreatic Adenocarcinoma
  • Stage III Pancreatic Cancer AJCC v8
  • Stage IV Pancreatic Cancer AJCC v8
  • Unresectable Malignant Solid Neoplasm
  • Unresectable Pancreatic Adenocarcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT05226507 | TERMINATED | PHASE1
45 participants

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2021-12-31
Completion:
2025-01-01
Conditions
  • Advanced Solid Tumor
  • Ovarian Cancer
  • Ovarian Clear Cell Carcinoma
  • Ovarian Clear Cell Tumor
  • Ovarian Clear Cell Adenocarcinoma
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian Endometrioid Tumor
  • ARID1A Gene Mutation
Interventions
  • DRUG
No Results Yet
NCT05207059 | ACTIVE_NOT_RECRUITING | NA
500 participants

Healthy Early Life Moments in Singapore

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2022-03-18
Completion:
2027-12-31
Conditions
  • Metabolic Disease
  • Mental Health Wellness 1
  • Lifestyle Risk Reduction
  • Maternal Obesity
Interventions
  • BEHAVIORAL
No Results Yet
NCT05064709 | RECRUITING | NA
1500 participants

Assessment of CCM in HF With Higher Ejection Fraction

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2022-02-03
Completion:
2029-02-01
Conditions
  • Heart Failure
  • Heart Failure With Preserved Ejection Fraction
  • Heart Failure With Mid Range Ejection Fraction
  • Heart Failure With Moderately Reduced Ejection Fraction
  • Diastolic Heart Failure
Interventions
  • DEVICE
No Results Yet
NCT05006716 | RECRUITING | PHASE1/PHASE2
645 participants

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2021-09-13
Completion:
2026-11-30
Conditions
  • B-cell Malignancy
  • Marginal Zone Lymphoma
  • Follicular Lymphoma
  • Non-Hodgkin Lymphoma
  • Waldenström Macroglobulinemia
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Mantle Cell Lymphoma
  • Diffuse Large B Cell Lymphoma
Interventions
  • DRUG
No Results Yet
NCT04969094 | ACTIVE_NOT_RECRUITING | NA
81 participants

Reducing Fall Risk With NMES

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2022-01-04
Completion:
2026-12-20
Conditions
  • Falls
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page